CINECA IRIS Institutional Research Information System

CHIELLINI, GRAZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.936
AS - Asia 7.097
EU - Europa 6.298
SA - Sud America 978
Continente sconosciuto - Info sul continente non disponibili 391
AF - Africa 294
OC - Oceania 11
Totale 31.005
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.434
IT - Italia 2.372
SG - Singapore 2.129
CN - Cina 2.042
HK - Hong Kong 1.198
SE - Svezia 1.022
BR - Brasile 785
VN - Vietnam 585
DE - Germania 568
BG - Bulgaria 474
CA - Canada 375
FR - Francia 307
UA - Ucraina 276
TR - Turchia 273
GB - Regno Unito 272
FI - Finlandia 244
RU - Federazione Russa 206
KR - Corea 187
AT - Austria 178
JP - Giappone 176
IN - India 155
CH - Svizzera 139
CI - Costa d'Avorio 128
AR - Argentina 66
BD - Bangladesh 66
PL - Polonia 46
MX - Messico 40
NL - Olanda 37
IQ - Iraq 36
PK - Pakistan 35
ID - Indonesia 33
ZA - Sudafrica 33
BE - Belgio 31
EC - Ecuador 30
MA - Marocco 29
ES - Italia 28
SA - Arabia Saudita 28
CO - Colombia 23
SN - Senegal 21
PE - Perù 20
CR - Costa Rica 19
CZ - Repubblica Ceca 19
UZ - Uzbekistan 19
KE - Kenya 17
NG - Nigeria 17
JM - Giamaica 16
VE - Venezuela 16
MY - Malesia 15
CL - Cile 14
EG - Egitto 14
GR - Grecia 14
IE - Irlanda 13
IR - Iran 13
PH - Filippine 13
AE - Emirati Arabi Uniti 12
AZ - Azerbaigian 10
JO - Giordania 10
PY - Paraguay 10
TN - Tunisia 10
TT - Trinidad e Tobago 10
NP - Nepal 9
UY - Uruguay 9
AU - Australia 8
IL - Israele 8
AL - Albania 7
EU - Europa 7
HN - Honduras 7
NO - Norvegia 7
TW - Taiwan 7
AF - Afghanistan, Repubblica islamica di 6
LT - Lituania 6
OM - Oman 6
PT - Portogallo 6
SV - El Salvador 6
BJ - Benin 5
DZ - Algeria 5
KZ - Kazakistan 5
NI - Nicaragua 5
PA - Panama 5
BB - Barbados 4
BY - Bielorussia 4
DO - Repubblica Dominicana 4
GT - Guatemala 4
RO - Romania 4
KG - Kirghizistan 3
KW - Kuwait 3
LU - Lussemburgo 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
AO - Angola 2
BO - Bolivia 2
BW - Botswana 2
CG - Congo 2
DK - Danimarca 2
ET - Etiopia 2
GY - Guiana 2
HR - Croazia 2
HU - Ungheria 2
KH - Cambogia 2
Totale 30.590
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.678
Ashburn 1.483
Ann Arbor 1.296
Singapore 1.244
Hong Kong 1.181
San Jose 982
Chandler 832
Houston 813
Fairfield 800
Dallas 748
Milan 712
Santa Clara 624
Sofia 473
Beijing 432
Shanghai 429
Jacksonville 389
Wilmington 345
New York 317
Seattle 309
Serra 306
Council Bluffs 297
Ottawa 272
Cambridge 260
Boardman 249
Hefei 230
Princeton 229
Pisa 219
Los Angeles 195
Lawrence 183
Seoul 182
Izmir 173
Tokyo 169
Lauterbourg 165
Nanjing 164
Vienna 164
Medford 156
Ho Chi Minh City 153
Abidjan 128
Bern 118
Rome 103
Frankfurt am Main 102
Hanoi 98
Buffalo 96
Des Moines 88
Dong Ket 81
Istanbul 76
Dearborn 75
Jüchen 70
Redondo Beach 69
London 66
Helsinki 65
Nanchang 65
São Paulo 64
Florence 59
Munich 53
Chicago 51
Columbus 51
San Diego 50
Kunming 47
Redwood City 42
Carrara 41
The Dalles 37
Hebei 36
Bremen 35
Montreal 35
Pune 35
Ogden 33
Orem 33
Marseille 32
Warsaw 32
Brussels 30
Norwalk 28
Lucca 27
Hyderabad 25
Jiaxing 25
Middleton 24
Nuremberg 24
Phoenix 24
San Francisco 24
Shenyang 24
Tianjin 24
Boulder 23
Brooklyn 23
Haiphong 23
Livorno 23
Rio de Janeiro 23
Washington 23
Boston 22
Dakar 21
Johannesburg 21
Turku 21
Brasília 20
Da Nang 20
Belo Horizonte 19
Düsseldorf 19
Changsha 18
Chennai 18
Denver 18
Falls Church 18
Hangzhou 18
Totale 21.589
Salva come PNG Salva come JPEG
Nome #
Effects of Thyroid Hormones and their Metabolites on Learning and Memory in Normal and Pathological Conditions 266
A high-affinity subtype-selective agonist ligand for the thyroid hormone receptor 256
Dual inhibition of PDK1 and Aurora Kinase A: an effective strategy to induce differentiation and apoptosis of human glioblastoma multiforme stem cells 242
Ultrastructural Localization of Histidine-rich Glycoprotein in Skeletal Muscle Fibers: Colocalization With AMP Deaminase 237
Memantine prodrug as a new agent for alzheimer’s disease 232
Development and primary characterization of a human thyroid organoid in vitro model for thyroid metabolism investigation 223
Modulation of Gene Expression by 3-Iodothyronamine: Genetic Evidence for a Lipolytic Pattern 222
3-Iodothyronamine affects calcium handling in rat ventricular cardiomyocytes 220
The pleiotropic functionality of endogenous 3-iodothyronamine (T1AM) and synthetic thyronamine-like analogs: a powerful tool to target interlinked diseases such as obesity and neurodegeneration 219
The [(Methyloxy)imino]methyl Moiety as a Bioisoster of Aryl. A Novel Class of Completely Aliphatic Beta-Adrenergic Receptor Antagonists 211
3-Iodothyronamine modulates sarcoplasmic reticulum calcium release 209
Cardioprotective effect of 3-iodothyronamine in perfused rat heart subjected to ischemia and reperfusion. 208
Design, Synthesis, and Biological Activity of New CB2 Receptor Ligands: from Orthosteric and Allosteric Modulators to Dualsteric/Bitopic Ligands 208
3-Iodothyronamine as a novel endogenous chemical messenger: tissue distribution and catabolism 207
Stimulation of cardiac trace amine receptors by 3-iodothyronamine modulates tyrosine phosphorylation and induces cardioprotection 206
New Insights into Bitopic Orthosteric/Allosteric Ligands of Cannabinoid Receptor Type 2 204
Endogenous TH metabolite 3-iodothyronamine (T1AM) and synthetic thyronamine-like analogues SG-1 and SG-2 induce autophagy in human glioblastoma cells (U-87MG) 204
(Z)-(Methyloxyiminomethyl)ethanolamines. Effects of the configuration around the iminic double bond on the beta-adrenergic affinity of moim-type beta-adrenergic blocking agents 197
Stimulation of cardiac trace amine receptors by 3-iodothyronamine modulates tyrosine phosphorylation and induces cardioprotection 197
New Insights into the Potential Roles of 3-Iodothyronamine (T1AM) and Newly Developed Thyronamine-Like TAAR1 Agonists in Neuroprotection 195
3-iodothyronamine as a potential anti-tumor compound 194
Conformationally restrained ß-blocking oxime ethers. 2. Synthesis and ß-adrenergic properties of diastereoisomeric anti and syn 2-(5’-(3’-aryl-substituted)isoxazolidinyl)-N-alkylethanolamines 193
Cardioprotection by 3-iodothyronamine, a new endogenous chemical messenger 193
Synthesis and ß-adrenergic properties of (E)-N-[3-(alkylamino)-2- hydroxypropilidene](methyloxy)amines substituted with an aromatic group on their [(methyloxy)imino]methyl moiety (MOIMM): an investigation into the biopharmacological effects of an aryl substitution in the class of MOIM ß-blocking drugs. 192
Synthesis and biological activities of vitamin D-like inhibitors of CYP24 hydroxylase 192
3-Iodothyronamine (T(1)AM) induces variation in phosphorylation pattern of tyrosine residues in rat heart 190
Conformationally Restrained Analogs of Sympathomimetic Catecholamines. Synthesis, Conformational Analysis, and Adrenergic Activity of Isochroman Derivatives 190
3-Iodothyronamine affects calcium handling in isolated cardiomyocytes 189
3-Iodothyronamine as a Novel Endogenous Chemical Messenger: Tissue Distribution and Catabolism. 189
Thyroid hormone-sympathetic interaction and adaptive thermogenesis are thyroid hormone receptor isoform-specific 188
Metabolic reprogramming by 3-Iodothyronamine (T1AM): a new perspective to reverse obesity through co-regulation of sirtuin 4 and 6 expression 187
WEIGHT LOSS WITH PRESERVED GLUCOSE HOMEOSTASIS DURING CHRONIC TREATMENT OF OBESE MICE WITH 3-IODOTHYRONAMINE (T1AM): ROLE OF THE SIRTUIN FAMILY 186
Different configurations of specific thyroid hormone response elements mediate opposite effects of thyroid hormone and GC-1 on gene expression 185
An efficient substitution reaction for the preparation of thyroid hormone analogues 184
Electron microscope localization of A1 adenosine receptors in human neutrophils 183
A new signalling pathway mediated by 3-iodothyronamine in rat heart 182
Cardiac effects of trace amines: pharmacological characterization of trace amine-associated receptors 182
2-methylene-19-nor-(23S)-25-dehydro-1.alpha.-hydroxyvitamin D.sub.3-26,23-lactone and 2-methylene-19-nor-(23R)-25-dehydro-1.alpha.-hydroxyvitamin D.sub.3-26,23-lactone 182
In the brain of mice, 3-iodothyronamine (T1AM) is converted into 3-iodothyroacetic acid (TA1) and it is included within the signaling network connecting thyroid hormone metabolites with histamine 181
Delivery of thyronamines (Tams) to the brain: A preliminary study 181
Endogenous 3-iodothyronamine (T1Am) and synthetic thyronamine-like analog SG-2 act as novel pleiotropic neuroprotective agents through the modulation of SIRT6 181
Design of thyroid hormone receptor antagonists from first principles 179
The thyroid hormone receptor-beta agonist GC-1 induces cell proliferation in rat liver and pancreas 178
Modulation of Cardiac Inotropic State by 3-Iodothyronamine: Evidence for a Novel Signalling Pathway Mediated by Trace Amine-Associated Receptors 178
Design, synthesis and biological evaluation of novel TRβ selective agonists sustained by ADME-toxicity analysis 178
3-Iodothyronamine Modulates Sarcoplasmic Reticulum Calcium Release 177
Effects of Zofenopril on Cardiac Sarcoplasmic Reticulum Calcium Handling 177
Cardioprotection by ranolazine in perfused rat heart 177
Deciphering the potential of 3-iodothyronamine (T1AM) in regulating lipid metabolism 177
FLUORESCENT PROBE SPECIFICALLY LABELS A1 ADENOSINE RECEPTOR IN BOVINE CORONARY ARTERY. 175
Synthesis and ß-Adrenergic Properties Of (Z)-N-[3-(Alkylamino)-2-hydroxypropilidene](aryl-methyloxy)amines: Effects Of The Configuration Around The Methyloxyiminomethyl(MOIM) Double Bond On The Biopharmacological Properties Of MOIM-type ß-Blocking Agents 174
2-Methylene-(20S,25R)-19,26-Dinor-Vitamin D Analogs 174
Sintesi e proprietà beta-adrenergiche di [(benzilideneammino)ossi] propanolammine orto-ossipropanolammine sostituite chirali, 172
The importance of stereochemistry on the actions of vitamin D. 172
Cardiac effects of trace amines: Pharmacological characterization of trace amine-associated receptors 172
Distribution of exogenous [125I]-3-iodothyronamine in mouse in vivo: relationship with trace amine-associated receptors. 172
ADENOSINE RECEPTORS: NEW PERSPECTIVE BY THE USE OF AGONIST-DERIVED MOLECULAR PROBES. 171
3-Iodothyronamine (T1AM) modifies tyrosine phosphorylation pattern in rat heart 170
Evaluation of 3-iodothyronamine (T1AM) in cell preparation, tissue homogenates and biological fluids by HPLC-ESI-MS-MS 170
Selective Thyroid Hormone Receptor-Beta (TRβ) Agonists: New Perspectives for the Treatment of Metabolic and Neurodegenerative Disorders 169
3-iodothyronamine is a novel endogenous modulator of cardiac inotropic state 168
3-Iodothyronamine (T1AM) induces variation in the phosphorylation pattern of thyrosine residues in rat heart 167
Administration of 3-Iodothyronamine (T1AM) Affects Gene Expression in the Rat Adipose Tissue Cells. 167
Tissue Distribution and Cardiac Metabolism of 3-Iodothyronamine 167
New Insights into the Effects of 3-Iodothyronamine (T1AM) on Metabolism in Mice from Cavity Ring Down Spectroscopy (CRDS) 166
An Efficient Aequorea victoria Green Fluorescent Protein for Stimulated Emission Depletion Super-Resolution Microscopy 166
3-Iodothyronamine (T1AM) signalling pathway involves tyrosine phosphorylation in rat heart 165
(E)-(ARYLMETHYLENEAMINOXY)ACETAMIDES AS ANALOGS OF NEUROLEPTIC BENZAMIDES - SYNTHESIS AND D-2-DOPAMINERGIC BINDING-AFFINITY 165
SG‐2: A SYNTHETIC ANALOG OF THYROID HORMONE METABOLITE 3‐IODOTHYRONAMINE (T1AM), PREVENTS β‐AMYLOID NEUROTOXICITY IN VITRO 165
8.1.4 – Biological Vesicles and Platforms – Cyclodextrin-based platforms as RNA delivery systems 164
Synthesis and biological properties of 2-methylene-19-nor-25-dehydro-1alpha-hydroxyvitamin D(3)-26,23-lactones--weak agonists 163
3-Iodothyronamine metabolism and functional effects in FRTL5 thyroid cells. 163
Discovery of pyridoquinoxaline-based new P-gp inhibitors as coadjutant against Multi Drug Resistance in cancer 162
2-methylene-(20S,25S)-19,26-dinor-vitamin D analogs 162
The Interplay between Cannabinoid Receptors and Microglia in the Pathophysiology of Alzheimer's Disease 161
Cardiac metabolism of 3-iodothyronamine 161
A-ring analogs of 1,25-dihydroxyvitamin D-3 161
A NOVEL HPLC-MS-MS METHOD TO ASSAY TISSUE THYROID HORMONES 161
The TR-beta selective agonist, GC-1, stimulates mitochondrial oxidative processes to a lesser extent than triiodothyronine 160
Metabolic profiling reveals reprogramming of lipid metabolic pathways in treatment of polycystic ovary syndrome with 3-iodothyronamine 159
Recovery of 3-iodothyronamine and derivatives in biological matrices: problems and pitfalls 159
Performance in Behavioral Testing in an Animal Model of Post-Surgical Hypoparathyroidism 159
Cardiac effects of thyronamines 158
Modulation of cardiac calcium homeostasis by 3-iodothyronamine 158
Removal of the 26-methyl group from 19-nor-1a,25-dihydroxyvitamin D3 markedly reduces in vivo calcemic activity without altering in vitro VDR binding, HL-60 cell differentiation, and transcription. 157
Quantification of serum 25-hydroxyvitamin D: a comparison among immunoassay, HPLC-UV, and HPLC-MS 157
Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function 157
Synthesis and biological activity of novel thyroid hormone analogues: 5 '-aryl substituted GC-1 derivatives 156
Optical imaging of mitochondrial redox state in rodent models with 3-iodothyronamine. 156
Synthesis and Biological Evaluation of Cyclopropylamine Vitamin D‐Like CYP24A1 Inhibitors 156
Modulation of cardiac inotropic state by 3-iodothyronamine: evidence for a novel signalling pathway mediated by trace amine-associated receptors 155
New Multitarget Approaches in the War Against Glioblastoma: A Mini-Perspective 155
Multi-targeted ChEI-copper chelating molecules as neuroprotective agents 155
Thyroxine metabolite-derived 3-iodothyronamine (T1AM) and synthetic analogs as efficient suppressors of transthyretin amyloidosis 153
Modulation of cardiac inotropic state by a novel thyroid hormone analog acting via non genomic mechanism 153
2-methylene-19-nor-(23S)-25-dehydro-1.alpha.-hydroxyvitamin D.sub.3-26,23-lactone and 2-methylene-19-nor-(23R)-25-dehydro 1.alpha.-hydroxyvitamin D.sub.3-26,23-lactone 153
Effects of 3-Iodothyronamine on Sarcoplasmic Reticulum Calcium Release in Rat Heart 153
New insights into the thyroid endocrine system by HPLC-ESI-MS-MS 153
3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone 153
SUN-717 SG-2 a Novel Multi-Target Directed Ligand (MTDL) for the Treatment of Neurodegenerative Diseases (NDDS) 152
Totale 17.980
Salva come PNG Salva come JPEG
Categoria #
all - tutte 85.652
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.652
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.871 0 0 45 133 383 292 43 89 87 86 134 579
2022/20232.682 387 337 192 265 290 373 14 172 446 16 116 74
2023/20242.446 429 278 275 213 346 344 88 75 36 46 50 266
2024/20255.534 36 236 103 264 476 493 501 305 577 827 638 1.078
2025/20267.063 466 869 861 752 601 608 1.025 277 503 506 381 214
2026/20271.487 181 548 758 0 0 0 0 0 0 0 0 0
Totale 31.005